World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 73 2127 1952 1034 938 123 20935

Carol O. Tacket publications per year

The chart shows the history of publications by Carol O. Tacket between 1982 and 2016, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Carol O. Tacket published across 35 years, from 1982 to 2016, averaging 3.5 papers a year. Output peaked at 11 publications in 1992. 2 of the 124 publications appeared in the last two years.

No. of publications
2 4 6 8 10
Bar chart. Horizontal axis: year, 1982 to 2016. Vertical axis: number of publications, 0 to 11. Peak 11 publications in 1992. 1982: 5 publications 1983: 4 publications 1984: 5 publications 1985: 2 publications 1986: 2 publications 1987: 2 publications 1988: 3 publications 1989: 3 publications 1990: 6 publications 1991: 6 publications 1992: 11 publications 1993: 8 publications 1994: 6 publications 1995: 4 publications 1996: 3 publications 1997: 6 publications 1998: 7 publications 1999: 5 publications 2000: 6 publications 2001: 1 publication 2002: 1 publication 2003: 3 publications 2004: 7 publications 2005: 2 publications 2006: 0 publications 2007: 4 publications 2008: 3 publications 2009: 1 publication 2010: 2 publications 2011: 2 publications 2012: 0 publications 2013: 1 publication 2014: 1 publication 2015: 0 publications 2016: 2 publications
1982 2016

124 publications in total across all disciplines

View publications per year as a table
Carol O. Tacket: publications per year, 1982 to 2016
Year Publications
1982 5
1983 4
1984 5
1985 2
1986 2
1987 2
1988 3
1989 3
1990 6
1991 6
1992 11
1993 8
1994 6
1995 4
1996 3
1997 6
1998 7
1999 5
2000 6
2001 1
2002 1
2003 3
2004 7
2005 2
2006 0
2007 4
2008 3
2009 1
2010 2
2011 2
2012 0
2013 1
2014 1
2015 0
2016 2
Total 124
Download as CSV

Carol O. Tacket publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Carol O. Tacket sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 122–131 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 123 publications — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150 123
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Carol O. Tacket D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Carol O. Tacket sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 72–73 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 73 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184 73
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Overview

Carol O. Tacket is affiliated with the University of Maryland, Baltimore in the United States. Their academic profile does not currently include any listed recent papers, frequent co-authors, or specific publication venues. Likewise, no specific book publications or awards have been documented.

Although detailed information about their research topics, fields of study, or subfields is not provided, their association with a major research university suggests involvement in scholarly activities within their institutional environment.

Available data does not specify any main topics of work or areas of expertise, nor are there records of notable collaborative relationships or publication patterns in leading academic venues.

The absence of published papers in the immediate data indicates either emerging research activities or a focus on roles beyond documented publication, such as teaching, administration, or practice within their discipline.

Best Publications

  • Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato.

    Carol O. Tacket;Hugh S. Mason;Genevieve Losonsky;John D. Clements

  • HUMAN IMMUNE RESPONSES TO A NOVEL NORWALK VIRUS VACCINE DELIVERED IN TRANSGENIC POTATOES

    Carol O. Tacket;Hugh S. Mason;Genevieve Losonsky;Mary K. Estes

  • Heterogeneity of enteroaggregative Escherichia coli virulence demonstrated in volunteers.

    James P. Nataro;Deng Yikang;Susan Cookson;Alejandro Cravioto

  • Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli.

    Carol O. Tacket;Genevieve Losonsky;Harriet Link;Yen Hoang

  • Clinical Features and an Epidemiological Study of Vibrio vulnificus Infections

    Carol O. Tacket;Frances Brenner;Paul A. Blake

  • Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218

    R Edelman;C O Tacket;S S Wasserman;S A Bodison

  • Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection.

    M S Donnenberg;C O Tacket;S P James;G Losonsky

  • Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR.

    MyronM. Levine;Deirdre Herrington;Genevieve Losonsky;Ben Tall

  • Clinical responses to undiluted and diluted smallpox vaccine.

    Sharon E. Frey;Robert B. Couch;Carol O. Tacket;John J. Treanor

  • Comparison of the safety and immunogenicity of delta aroC delta aroD and delta cya delta crp Salmonella typhi strains in adult volunteers.

    C O Tacket;D M Hone;rd R Curtiss;S M Kelly

  • Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans.

    Carol O. Tacket;Marcelo B. Sztein;Genevieve A. Losonsky;Steven S. Wasserman

  • Adjuvanted Intranasal Norwalk Virus-Like Particle Vaccine Elicits Antibodies and Antibody-Secreting Cells That Express Homing Receptors for Mucosal and Peripheral Lymphoid Tissues

    Samer S. El-Kamary;Marcela F. Pasetti;Paul M. Mendelman;Sharon E. Frey

  • Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers.

    Carol O Tacket;Marcelo B Sztein;Genevieve A Losonsky;Steven S Wasserman

  • A plasmid of enterohemorrhagic Escherichia coli O157:H7 is required for expression of a new fimbrial antigen and for adhesion to epithelial cells.

    H Karch;J Heesemann;R Laufs;A D O'Brien

  • Phase 1 safety and immune response studies of a DNA vaccine encoding hepatitis B surface antigen delivered by a gene delivery device.

    Carol O Tacket;Michael J Roy;Georg Widera;William F Swain

  • Progress in vaccines against typhoid fever.

    Myron M. Levine;Catterine Ferreccio;Robert E. Black;Carol O. Tacket

  • Immunogenicity of recombinant LT-B delivered orally to humans in transgenic corn.

    Carol O. Tacket;Marcela F. Pasetti;Robert Edelman;John A. Howard

  • Efficacy of Bovine Milk Immunoglobulin Concentrate in Preventing Illness after Shigella Flexneri Challenge

    Carol O. Tacket;Steven B. Binion;Eileen Bostwick;Genevieve Losonsky

  • Phase 2 clinical trial of attenuated Salmonella enterica serovar Typhi oral live vector vaccine CVD 908-htrA in U.S. Volunteers

    Carol O. Tacket;Marcelo B. Sztein;Steven S. Wasserman;Genevieve Losonsky

  • Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination.

    Carol O. Tacket;Mitchell B. Cohen;Steven S. Wasserman;Genevieve Losonsky

  • Safety of Live OralSalmonella typhiVaccine Strains with Deletions inhtrAandaroC aroDand Immune Response in Humans

    Carol O. Tacket;Marcelo B. Sztein;Genevieve A. Losonsky;Steven S. Wasserman

Frequent Co-Authors

Myron M. Levine
Myron M. Levine University of Maryland, Baltimore
Genevieve Losonsky
Genevieve Losonsky University of Maryland, Baltimore
Robert R. Edelman
Robert R. Edelman Northwestern University
James P. Nataro
James P. Nataro University of Virginia
Marcelo B. Sztein
Marcelo B. Sztein University of Maryland, Baltimore
Steven S. Wasserman
Steven S. Wasserman University of Virginia
Stanley J. Cryz
Stanley J. Cryz University of Massachusetts Chan Medical School
Marcela F. Pasetti
Marcela F. Pasetti University of Maryland, Baltimore
James B. Kaper
James B. Kaper University of Maryland, Baltimore
Gordon Dougan
Gordon Dougan University of Cambridge

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare fields through online degrees can broaden career opportunities. Many professionals pursue nursing pathways that complement immunological expertise, such as Psychiatric Nurse Practitioner roles. Those looking for affordability may find a great starting point through cheap psych np programs, which offer cost-effective routes to advanced practice nursing.

Career growth in these areas is promising. Understanding the dnp salary landscape helps prospective students weigh their investment against potential earnings. Doctor of Nursing Practice degrees provide strong financial incentives, especially in states with high demand for advanced practice nurses.

For those already practicing as Family Nurse Practitioners, transitioning to specialized care can open new horizons. Guidance on how to make this shift is detailed in resources on fnp to acute care certification, allowing practitioners to target acute care settings that often engage immunology-related cases.

Additionally, accelerated options such as those highlighted in the accelerated fnp program category enable quicker entry into the nursing workforce while still covering critical knowledge areas. These programs balance speed and quality, supporting timely career advancement in immunology-adjacent fields.

Best Scientists Citing Carol O. Tacket

Recently Published Articles